CD8A and melanoma: In line with the results in murine melanoma and other human tumors, in treatment‐naïve melanoma patients the TEC subtype displaying the muTECHigh/autophagyLow phenotype was associated with clinical responses and with a higher number of tumor‐infiltrating CD8+ T‐cells, further suggesting the functional association between TEC‐autophagy and suppression of immune‐related responses.